|
SLC37A3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.944000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.931200E-01 |
| Normal-vs-Stage2 |
5.044200E-01 |
| Normal-vs-Stage3 |
9.900800E-01 |
| Normal-vs-Stage4 |
2.190400E-01 |
| Stage1-vs-Stage2 |
8.036000E-01 |
| Stage1-vs-Stage3 |
4.523800E-01 |
| Stage1-vs-Stage4 |
4.324400E-01 |
| Stage2-vs-Stage3 |
4.924200E-01 |
| Stage2-vs-Stage4 |
7.413200E-01 |
| Stage3-vs-Stage4 |
2.220400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.948800E-01 |
| Normal-vs-AfricanAmerican |
8.368400E-01 |
| Normal-vs-Asian |
3.179600E-01 |
| Caucasian-vs-AfricanAmerican |
8.123000E-01 |
| Caucasian-vs-Asian |
3.540400E-01 |
| AfricanAmerican-vs-Asian |
3.392600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.478000E-01 |
| Normal-vs-Female |
8.525800E-01 |
| Male-vs-Female |
5.920100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.624600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.627000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.682800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.277770E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.048000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.363600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.210600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.813800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.798200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.191630E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.742600E-01 |
| Normal-vs-Grade 2 |
4.015800E-01 |
| Normal-vs-Grade 3 |
2.899000E-01 |
| Normal-vs-Grade 4 |
1.502780E-01 |
| Grade 1-vs-Grade 2 |
8.021400E-01 |
| Grade 1-vs-Grade 3 |
7.218600E-01 |
| Grade 1-vs-Grade 4 |
3.251400E-01 |
| Grade 2-vs-Grade 3 |
8.015600E-01 |
| Grade 2-vs-Grade 4 |
6.977900E-03 |
| Grade 3-vs-Grade 4 |
5.896300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.633000E-01 |
| Normal-vs-ccB subtype |
4.199600E-01 |
| ccA subtype-vs-ccB subtype |
9.957000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.568800E-01 |
| Normal-vs-N1 |
4.019000E-01 |
| N0-vs-N1 |
4.726200E-01 |
|
|
